{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Bladder pain syndrome", "Interstitial cystitis", "O'Leary\u2013Sant symptom index", "Ozone", "Ozone therapy"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "36242631", "DateCompleted": {"Year": "2023", "Month": "06", "Day": "26"}, "DateRevised": {"Year": "2023", "Month": "06", "Day": "26"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2022", "Month": "10", "Day": "15"}], "ELocationID": ["10.1007/s00192-022-05383-3"], "Journal": {"ISSN": "1433-3023", "JournalIssue": {"Volume": "34", "Issue": "7", "PubDate": {"Year": "2023", "Month": "Jul"}}, "Title": "International urogynecology journal", "ISOAbbreviation": "Int Urogynecol J"}, "ArticleTitle": "Effectiveness of intravesical ozone in interstitial cystitis by the O'Leary-Sant symptom index.", "Pagination": {"StartPage": "1437", "EndPage": "1446", "MedlinePgn": "1437-1446"}, "Abstract": {"AbstractText": ["A prospective clinical, preliminary study was performed in patients with interstitial cystitis/bladder pain syndrome (IC/BPS) who were nonresponders to conventional treatment and received intravesical ozone as a therapeutic alternative.", "Sixteen patients received six applications of intravesical ozone at a concentration of 41 \u03bcg/mL. We evaluated therapeutic efficacy by the percentage reduction of Interstitial Cystitis Symptom and Problem Index scores (ICSI/ICPI-the O'Leary-Sant symptom index), recurrence rate, nonresponse, and side effects in scores collected on admission (pre-treatment), at the end of the therapeutic protocol (post-treatment), and 180 days (follow-up) after the last ozone application.", "The mean age of women was 52.9 years (SD: 15.5), and the duration of symptoms was 5.7 years (SD: 7.1). The median ICSI on admission was 17 (IQR: 14.25-19.5) and at follow-up was 0.5 (IQR: 0-2), with a reduction of 97.5% (CI: 85.7-100). The median ICSI/ICPI on admission was 31.5 (IQR: 29-35.2) and at follow-up was 2.0 (IQR: 0-3.75), with a reduction of 92.3% (CI: 88.8-100). The recurrence rate was only 6.25%, and no patients were nonresponders to the treatment.", "The application of intravesical ozone was effective in the treatment of patients with IC/BPS who were nonresponders to conventional therapy, showing a progressive and safe effect, at least in the short term."], "CopyrightInformation": "\u00a9 2022. The International Urogynecological Association."}, "AuthorList": [{"Identifier": ["0000-0002-2674-8047"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biomedical Engineering Institute, Anhembi Morumbi University (UAM), Rua Casa do Ator, 275, S\u00e3o Paulo, SP, 04546-001, Brazil. mariaveronicapires46@gmail.com."}], "LastName": "Pires", "ForeName": "Maria Ver\u00f4nica", "Initials": "MV"}, {"Identifier": ["0000-0001-6736-2100"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biomedical Engineering Institute, Anhembi Morumbi University (UAM), Rua Casa do Ator, 275, S\u00e3o Paulo, SP, 04546-001, Brazil."}, {"Identifier": [], "Affiliation": "Center for Innovation, Technology, and Education (CIT\u00c9), S\u00e3o Jos\u00e9 dos Campos Technological Park, Estrada Dr. Altino Bondensan, 500, S\u00e3o Jos\u00e9 dos Campos, SP, 12247-016, Brazil."}], "LastName": "de Lima", "ForeName": "Carlos Jos\u00e9", "Initials": "CJ"}, {"Identifier": ["0000-0003-0806-4132"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Innovation, Technology, and Education (CIT\u00c9), S\u00e3o Jos\u00e9 dos Campos Technological Park, Estrada Dr. Altino Bondensan, 500, S\u00e3o Jos\u00e9 dos Campos, SP, 12247-016, Brazil."}, {"Identifier": [], "Affiliation": "The Federal University of Technology - Paran\u00e1 (UTFPR), Via Marginal Rosalina Maria dos Santos, 1233, Bloco B, Campo Mour\u00e3o, PR, 87301-899, Brazil."}], "LastName": "Carvalho", "ForeName": "Henrique Cunha", "Initials": "HC"}, {"Identifier": ["0000-0001-6432-7596"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biomedical Engineering Institute, Anhembi Morumbi University (UAM), Rua Casa do Ator, 275, S\u00e3o Paulo, SP, 04546-001, Brazil."}, {"Identifier": [], "Affiliation": "Center for Innovation, Technology, and Education (CIT\u00c9), S\u00e3o Jos\u00e9 dos Campos Technological Park, Estrada Dr. Altino Bondensan, 500, S\u00e3o Jos\u00e9 dos Campos, SP, 12247-016, Brazil."}], "LastName": "Moreira", "ForeName": "L\u00edvia Helena", "Initials": "LH"}, {"Identifier": ["0000-0002-1794-0790"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biomedical Engineering Institute, Anhembi Morumbi University (UAM), Rua Casa do Ator, 275, S\u00e3o Paulo, SP, 04546-001, Brazil."}, {"Identifier": [], "Affiliation": "Center for Innovation, Technology, and Education (CIT\u00c9), S\u00e3o Jos\u00e9 dos Campos Technological Park, Estrada Dr. Altino Bondensan, 500, S\u00e3o Jos\u00e9 dos Campos, SP, 12247-016, Brazil."}], "LastName": "Fernandes", "ForeName": "Adriana Barrinha", "Initials": "AB"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Int Urogynecol J", "NlmUniqueID": "101567041", "ISSNLinking": "0937-3462"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["drug therapy", "diagnosis"], "DescriptorName": "Cystitis, Interstitial"}, {"QualifierName": [], "DescriptorName": "Prospective Studies"}, {"QualifierName": [], "DescriptorName": "Administration, Intravesical"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}], "CoiStatement": "None."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Akiyama Y, Luo Y, Hanno MP, et al. Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives. Int J Urol. 2020;27(6):491\u2013503. doi: 10.1111/iju.14229.", "ArticleIdList": ["10.1111/iju.14229", "PMC7768977", "32246572"]}, {"Citation": "Birder LA. Pathophysiology of interstitial cystitis. Int J Urol. 2019;26(Suppl 1):12\u201315. doi: 10.1111/iju.13985.", "ArticleIdList": ["10.1111/iju.13985", "31144735"]}, {"Citation": "Malde S, Palmisani S, Al-Kaisy A, et al. Guideline of guidelines: bladder pain syndrome. BJU Int. 2018;122(5):729\u2013743. doi: 10.1111/bju.14399.", "ArticleIdList": ["10.1111/bju.14399", "29777618"]}, {"Citation": "Cox A, Golda N, Nadeau G, et al. CUA guideline: Diagnosis and treatment of interstitial cystitis/bladder pain syndrome. Can Urol Assoc J. 2016;10(5-6):E136\u2013E155. doi: 10.5489/cuaj.3786.", "ArticleIdList": ["10.5489/cuaj.3786", "PMC5065402", "27790294"]}, {"Citation": "Hanno PM, Erickson D, Moldwin R, et al. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol. 2015;193(5):1545\u20131553. doi: 10.1016/j.juro.2015.01.086.", "ArticleIdList": ["10.1016/j.juro.2015.01.086", "25623737"]}, {"Citation": "Huffman MM, Slack A, Hoke M. Bladder pain syndrome. Prim Care. 2019;46(2):213\u2013221. doi: 10.1016/j.pop.2019.02.002.", "ArticleIdList": ["10.1016/j.pop.2019.02.002", "31030822"]}, {"Citation": "Patnaik SS, Lagan\u00e0 AS, Vitale SG, et al. Etiology, pathophysiology and biomarkers of interstitial cystitis/painful bladder syndrome. Arch Gynecol Obstet. 2017;295(6):1341\u20131359. doi: 10.1007/s00404-017-4364-2.", "ArticleIdList": ["10.1007/s00404-017-4364-2", "28391486"]}, {"Citation": "Garzon S, Lagan\u00e0 AS, Casarin J, et al. An update on treatment options for interstitial cystitis. Menopause Rev. 2020;19(1):35\u201343. doi: 10.5114/pm.2020.95334.", "ArticleIdList": ["10.5114/pm.2020.95334", "PMC7258371", "32699542"]}, {"Citation": "Akiyama Y, Hanno MP. Phenotyping of interstitial cystitis/bladder pain syndrome. Int J Urol. 2019;1:17\u201319. doi: 10.1111/iju.13969.", "ArticleIdList": ["10.1111/iju.13969", "31144756"]}, {"Citation": "Giusto LL, Zahner PM, Shoskes DA. An evaluation of the pharmacotherapy for interstitial cystitis. Expert Opin Pharmacother. 2018;10:1097\u20131108. doi: 10.1080/14656566.2018.1491968.", "ArticleIdList": ["10.1080/14656566.2018.1491968", "29972328"]}, {"Citation": "Bosch PC. A randomized, double-blind, placebo-controlled trial of certolizumab pegol in women with refractory interstitial cystitis/bladder pain syndrome. Eur Urol. 2018;74(5):623\u2013630. doi: 10.1016/j.eururo.2018.07.026.", "ArticleIdList": ["10.1016/j.eururo.2018.07.026", "30072210"]}, {"Citation": "Sire A, Agostini F, Lippi L, et al. Oxygen-ozone therapy in the rehabilitation field: state of the art on mechanisms of action, safety and effectiveness in patients with musculoskeletal disorders. Biomolecules. 2021;11(3):356. doi: 10.3390/biom11030356.", "ArticleIdList": ["10.3390/biom11030356", "PMC7996934", "33652804"]}, {"Citation": "Bocci V. Ozone: A New Medical Drug. 2. Dordrecht: Springer; 2011."}, {"Citation": "Di Mauro R, Cantarella G, Bernardini R, et al. The biochemical and pharmacological properties of ozone: the smell of protection in acute and chronic diseases. Int J Mol Sci. 2019;20(3):634. doi: 10.3390/ijms20030634.", "ArticleIdList": ["10.3390/ijms20030634", "PMC6387239", "30717203"]}, {"Citation": "Hidalgo-Tall\u00f3n J, Cepero SM, Vilchez JS, et al. Ozone therapy as add-on treatment in fibromyalgia management by rectal insufflation: An open-label pilot study. J Altern Complement Med. 2013;19(3):238\u2013242. doi: 10.1089/acm.2011.0739.", "ArticleIdList": ["10.1089/acm.2011.0739", "23046293"]}, {"Citation": "Tirelli U, Cirrito C, Pavanello M. Ozone therapy in 40 patients with fibromyalgia: an effective therapy. Ozone. Therapy. 2018;3(3). 10.4081/ozone.2018.7969."}, {"Citation": "Bayrak O, Erturhan S, Seckiner I, et al. Chemical cystitis developed in experimental animals model: Topical effect of intravesical ozone application to bladder. Urol Ann. 2014;6(2):122\u2013126. doi: 10.4103/0974-7796.130553.", "ArticleIdList": ["10.4103/0974-7796.130553", "PMC4021650", "24833822"]}, {"Citation": "Tasdemir S, Tasdemir C, Vardi N, et al. Effects of ozone therapy on cyclophosphamide-induced urinary bladder toxicity in rats. Clin Invest Med. 2013;36(1):E9\u201317. doi: 10.25011/cim.v36i1.19400.", "ArticleIdList": ["10.25011/cim.v36i1.19400", "23374601"]}, {"Citation": "Teke K, Ozkan TA, Cebeci OO, et al. Preventive effect of intravesical ozone supplementation on n-methyl-n-nitrosourea-induced non-muscle invasive bladder cancer in male rats. Exp Anim. 2017;66(3):191\u2013198. doi: 10.1538/expanim.16-0093.", "ArticleIdList": ["10.1538/expanim.16-0093", "PMC5543239", "28228618"]}, {"Citation": "Wei A, Feng H, Jia X, et al. Ozone therapy ameliorates inflammation and endometrial injury in rats with pelvic inflammatory disease. Biomed Pharmacother. 2018;107:1418\u20131425. doi: 10.1016/j.biopha.2018.07.137.", "ArticleIdList": ["10.1016/j.biopha.2018.07.137", "30257358"]}, {"Citation": "O'Leary MP, Sant GR, Fowler FJ, et al. The interstitial cystitis symptom index and problem index. Urol. 1997;49(5):58\u201363. doi: 10.1016/S0090-4295(99)80333-1.", "ArticleIdList": ["10.1016/S0090-4295(99)80333-1", "9146003"]}, {"Citation": "Ogawa T, Ishizuka O, Ueda T, et al. Pharmacological management of interstitial cystitis /bladder pain syndrome and the role cyclosporine and other immunomodulating drugs play. Expert Rev Clin Pharmacol. 2018;11(5):495\u2013505. doi: 10.1080/17512433.2018.1457435.", "ArticleIdList": ["10.1080/17512433.2018.1457435", "29575959"]}, {"Citation": "Lubeck DP, Whitmore K, Sant GR, et al. Psychometric validation of the O\u2019Leary-Sant interstitial cystitis symptom index in a clinical trial of pentosan polysulfate sodium. Urol. 2001;57(6 Suppl 1):62\u201366. doi: 10.1016/s0090-4295(01)01126-8.", "ArticleIdList": ["10.1016/s0090-4295(01)01126-8", "11378052"]}, {"Citation": "Schwartz A, S\u00e1nchez GM, Sabbah F et al. Madrid Declaration on Ozone Therapy. 3rd Ed. International Scientific Committee of Ozone Therapy. 2020. https://www.isco3.org. Accessed 10 May 2022."}, {"Citation": "Viebahn-H\u00e4nsler R, Le\u00f3n Fern\u00e1ndez OS, Fahmy Z. Ozone in medicine: The low-dose ozone concept\u2014guidelines and treatment strategies. Ozone-Sci Eng. 2012;34(6):408\u2013424. doi: 10.1080/01919512.2012.717847.", "ArticleIdList": ["10.1080/01919512.2012.717847"]}, {"Citation": "Calleja-Agius J, Brincat MP. The urogenital system and the menopause. Climacteric. 2015;1:18\u201322. doi: 10.3109/13697137.2015.1078206.", "ArticleIdList": ["10.3109/13697137.2015.1078206", "26366796"]}, {"Citation": "Shan H, Zhang EW, Zhang P, et al. Differential expression of histamine receptors in the bladder wall tissues of patients with bladder pain syndrome/ interstitial cystitis \u2013 significance in the responsiveness to antihistamine treatment and disease symptoms. BMC Urol. 2019;19(1):115. doi: 10.1186/s12894-019-0548-3.", "ArticleIdList": ["10.1186/s12894-019-0548-3", "PMC6852726", "31718622"]}, {"Citation": "Neimark AI, Nepomnyashchikh LM, Lushnikova EL, et al. Microcirculation and structural reorganization of the bladder mucosa in chronic cystitis under conditions of ozone therapy. Bull Exp Biol Med. 2014;156(3):399\u2013405. doi: 10.1007/s10517-014-2358-7.", "ArticleIdList": ["10.1007/s10517-014-2358-7", "24771385"]}, {"Citation": "Hextall A, Cardozo L. The role of estrogen supplementation in lower urinary tract dysfunction. Int Urogynecol J Pelvic Floor Dysfunct. 2001;12(4):258\u2013261. doi: 10.1007/s001920170049.", "ArticleIdList": ["10.1007/s001920170049", "11569655"]}, {"Citation": "Watkins KE, Eberhart N, Hilton L, et al. Depressive disorders and panic attacks in women with bladder pain syndrome/interstitial cystitis: A population-based sample. Gen Hosp Psychiatry. 2011;33(2):143\u2013149. doi: 10.1016/j.genhosppsych.2011.01.004.", "ArticleIdList": ["10.1016/j.genhosppsych.2011.01.004", "PMC3099040", "21596207"]}, {"Citation": "McKernan LC, Bonnet KR, Finn MTM, et al. Qualitative analysis of treatment needs in interstitial cystitis/ bladder pain syndrome: Implications for intervention. Can J Pain. 2020;4(1):181\u2013198. doi: 10.1080/24740527.2020.1785854.", "ArticleIdList": ["10.1080/24740527.2020.1785854", "PMC7751614", "33367196"]}, {"Citation": "Tripp DA, Nickel JC, Krsmanovic A, et al. Depression and catastrophizing predict suicidal ideation in tertiary care patients with interstitial cystitis/bladder pain syndrome. Can Urol Assoc J. 2016;10(11-12):383\u2013388. doi: 10.5489/cuaj.3892.", "ArticleIdList": ["10.5489/cuaj.3892", "PMC5167592", "28096911"]}, {"Citation": "Clavo B, Navarro M, Federico M, Borrelli E, et al. Long-term results with adjuvant ozone therapy in the management of chronic pelvic pain secondary to cancer treatment. Pain Med. 2021;22(9):2138\u20132141. doi: 10.1093/pm/pnaa459.", "ArticleIdList": ["10.1093/pm/pnaa459", "PMC8557383", "33738491"]}, {"Citation": "Quaghebeur J, Wyndaele J. Bladder pain syndrome (BPS): Symptom differences between type 3C BPS and non-type 3C BPS. Scand J Urol. 2015;49(4):319\u2013320. doi: 10.3109/21681805.2014.982170.", "ArticleIdList": ["10.3109/21681805.2014.982170", "25428753"]}, {"Citation": "Logadottir Y, Hallsberg L, Fall M, et al. Bladder pain syndrome/interstitial cystitis ESSIC type 3C: High expression of inducible nitric oxide synthase in inflammatory cells. Scand J Urol. 2013;47(1):52\u201356. doi: 10.3109/00365599.2012.699100.", "ArticleIdList": ["10.3109/00365599.2012.699100", "22775390"]}, {"Citation": "Schulz S, Ninke S, Watzer B, et al. Ozone induces synthesis of systemic prostacyclin by cyclooxygenase-2 dependent mechanism in vivo. Biochem Pharmacol. 2012;83(4):506\u2013513. doi: 10.1016/j.bcp.2011.11.025.", "ArticleIdList": ["10.1016/j.bcp.2011.11.025", "22155309"]}, {"Citation": "Xing B, Chen H, Wang L, et al. Ozone oxidative preconditioning protects the rat kidney from reperfusion injury via modulation of the TLR4-NF-\u03baB pathway. Acta Cir Bras. 2015;30(1):60\u201366. doi: 10.1590/S0102-86502015001000008.", "ArticleIdList": ["10.1590/S0102-86502015001000008", "25627272"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "8", "Day": "2"}, {"Year": "2022", "Month": "9", "Day": "22"}, {"Year": "2023", "Month": "6", "Day": "26", "Hour": "6", "Minute": "41"}, {"Year": "2022", "Month": "10", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "10", "Day": "15", "Hour": "11", "Minute": "14"}, {"Year": "2022", "Month": "10", "Day": "15"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36242631", "PMC9569001", "10.1007/s00192-022-05383-3", "10.1007/s00192-022-05383-3"]}}], "PubmedBookArticle": []}